Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...
Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...
The Roivant company is dedicated to developing and commercializing innovative therapeutics in immune-dermatology.
As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis ...